• A unique collection of 2515 bioactive anti-infection compounds for high throughput screening (HTS) and high content screening (HCS).
• Targets such as Bacteria, Fungi, Parasite, CMV, HIV, SARS-CoV, Influenza Virus, etc.
• Bioactivity and safety confirmed by preclinical research and clinical trials, some have been approved by FDA.
• A useful tool to study infectious diseases or develop new anti-infection drugs.
• Structurally diverse, medicinally active, and cell permeable.
• More detailed compound information with structure, IC50, and other chemical & biological data.
• NMR and HPLC validated to ensure high purity and quality.
• All compounds are in stock and continuously updated.
|